SCD1 is also an important biomarker that can improve the survival of lung cancer stem cells, which are stabilized by EGFR to upregulate the synthesis of monounsaturated fatty acids and can promote the growth of lung cancer 46, 47. This evidence concerns the gene EGFR and lung carcinoma.